午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Pharmaceutical intermediates>Bulk Drug Intermediates>Baricitinib Impurity 93
Baricitinib Impurity 93
  • Baricitinib Impurity 93
  • Baricitinib Impurity 93
  • Baricitinib Impurity 93
  • Baricitinib Impurity 93
  • Baricitinib Impurity 93

Baricitinib Impurity 93 NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-02

Product Details

Product Name: Baricitinib Impurity 93 CAS No.: 1187595-85-2
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/07/02
Molecular formula: C7H10N2O2S

Baricitinib Impurity 93;1187595-85-2

Article illustration

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

  • Product Information

  • Product Number: B026093

  • English Name: Baricitinib Impurity 93

  • English Alias: 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile

  • CAS Number: 1187595-85-2

  • Molecular Formula: C?H??N?O?S

  • Molecular Weight: 186.23

  • Advantages

  • As a sulfur-containing heterocyclic impurity of baricitinib, the research advantages of this compound lie in:

  • Analyzing the by-product formation mechanism of sulfonylation and cyclization reactions during baricitinib synthesis to optimize processes for controlling sulfur-containing ylidene impurity generation;

  • Serving as a reference standard containing sulfonyl and nitrile groups to provide a standard substance for detecting polar heterocyclic impurities in drugs, improving the quantitative accuracy of methods such as LC-MS;

  • Helping study the impact of sulfur substituents and imine structures on drug stability and toxicological properties to provide a scientific basis for impurity control strategies.

  • Applications

  • Drug Development: Used as an impurity reference standard to identify and quantify Impurity 93 in baricitinib preparations, evaluating the purity of APIs and formulations;

  • Quality Control: Acting as a standard substance to validate the sensitivity of detection methods (e.g., HPLC or LC-MS), ensuring the impurity content meets ICH guideline requirements during production;

  • Toxicological Research: Assisting in evaluating the potential genotoxicity of sulfur-containing ylidene impurities to provide data support for drug safety evaluation.

  • Background Description

  • Baricitinib is a JAK inhibitor. If the sulfonylation reagent is excessive or the cyclization reaction conditions are out of control during its synthesis, azetidine impurities containing ethylsulfonyl groups (such as Impurity 93) are easily generated. Since sulfur-containing compounds may have potential oxidative toxicity and imine structures easily react with biological macromolecules, research on this impurity is a key link in baricitinib quality control and safety assessment.
  • Research Status

  • Current research focuses on:

  • Synthesis Methods: Developing high-purity synthesis processes for Impurity 93 to solve the purification challenges of sulfur-containing heterocyclic compounds and meet the needs of toxicological research;

  • Detection Technologies: Establishing trace detection methods (detection limits reach ppb level) for this impurity using ultra-high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) technology;

  • Toxicological Evaluation: Studying the potential mutagenicity of sulfonyl and nitrile structures through in vitro Ames tests and animal models;

  • Process Control: Analyzing the inducements (such as raw material residues, reaction temperature) of sulfonylation reactions to optimize the synthesis route and reduce the generation of this impurity.

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com





Company Profile Introduction

1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability. 2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs. 3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects. 4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes. 5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1kg
VIP1Y
Shaanxi Xianhe Biotech Co., Ltd
2025-04-17
$0.00/25KG
VIP1Y
Shaanxi Dideu New Materials Co. Ltd
2024-11-14
$0.00/1kg
VIP6Y
Jinan Jianfeng Chemical Co., Ltd
2024-08-09
$0.00/1kg
Nanjing Fred Technology Co., Ltd
2023-12-29
$2.00/1kg
VIP2Y
Jinan Million Pharmaceutical Co., Ltd
2023-08-15
$0.00/1kg
VIP3Y
Hangzhou ICH Biofarm Co., Ltd
2023-07-03
$0.00/1Kg
VIP4Y
Changzhou Rokechem Technology Co., Ltd.
2023-05-26
$0.00/1kg
VIP3Y
Henan Aochuang Chemical Co.,Ltd.
2022-09-30
$30.00/1KG
Wuhan wingroup Pharmaceutical Co., Ltd
2022-04-02
$20.00/1g/Bag
Pharmahands (Taizhou) Co., Ltd.
2020-09-15
INQUIRY